| __timestamp | Bristol-Myers Squibb Company | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 21226345 |
| Thursday, January 1, 2015 | 5920000000 | 87718074 |
| Friday, January 1, 2016 | 4940000000 | 93831530 |
| Sunday, January 1, 2017 | 6411000000 | 79419009 |
| Monday, January 1, 2018 | 6345000000 | 132166913 |
| Tuesday, January 1, 2019 | 6148000000 | 89124838 |
| Wednesday, January 1, 2020 | 11143000000 | 65782137 |
| Friday, January 1, 2021 | 10195000000 | 88845513 |
| Saturday, January 1, 2022 | 9509000000 | 134715000 |
| Sunday, January 1, 2023 | 9299000000 | 180142000 |
| Monday, January 1, 2024 | 11159000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Bristol-Myers Squibb Company and Intra-Cellular Therapies, Inc. have showcased contrasting R&D investment strategies. From 2014 to 2023, Bristol-Myers Squibb consistently invested heavily in R&D, with expenditures peaking in 2020 at over 11 billion dollars. This represents a staggering 145% increase from their 2014 spending. In contrast, Intra-Cellular Therapies, Inc., while significantly smaller, has shown a steady increase in R&D spending, culminating in a 2023 investment that is nearly 750% higher than their 2014 figures. This growth trajectory highlights their commitment to innovation despite their smaller scale. As these companies continue to navigate the evolving pharmaceutical landscape, their R&D investments will likely play a pivotal role in shaping their future successes.
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
Sanofi or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Cost of Revenue Comparison: Bristol-Myers Squibb Company vs Intra-Cellular Therapies, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
Research and Development Investment: Incyte Corporation vs Intra-Cellular Therapies, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Intra-Cellular Therapies, Inc. and Geron Corporation